Effects of interferon alpha on human osteoprogenitor cell growth and differentiation in vitro

Journal of Cellular Biochemistry

Volumn 74, Issue 3, 1999, Pages 372-385

  Oreffo, Richard O C ^a   Romberg, Silke ^a   Virdi, Amarjit S ^a   Joyner, Clive J ^a   Berven, Sigurd ^a   Triffitt, James T ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bone marrow; Differentiation; Interferon alpha; Osteoblast; Osteoprogenitor

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA INTERFERON; BONE MORPHOGENETIC PROTEIN; ESTROGEN RECEPTOR; MESSENGER RNA; OSTEOCALCIN;

ARTICLE; BONE TURNOVER; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; COLONY FORMING UNIT F; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; STEM CELL;

ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE MARROW; CELL COUNT; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; INTERFERON-ALPHA; OSTEOCALCIN; STEM CELLS; TIME FACTORS;

EID: 0033197924     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990901)74:3<372::AID-JCB6>3.0.CO;2-H     Document Type: Article

References (50)

1. Agarwala SS, Kirkwood JM. 1995. Potential uses of interferon alpha 2 as adjuvant therapy in cancer. Ann Surg Oncol 2:365-371.
2. Aguet M. 1991. Molecular cloning of interferon receptors: a short review. Br J Haematol 79 suppl 1:6-8.
3. Aman MJ, Bug G, Aulitzky WE, Huber C, Peschel C. 1996. Inhibition of interleukin-11 by interferon-alpha in human bone marrow stromal cells. Exp Hematol 24:863-867.
4. Aman MJ, Keller U, Derigs G, Mohamadzadeh M, Huber C, Peschel C. 1994. Regulation of cytokine expression by interferon alpha in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist. Blood 84:4142-4150.
5. Balkwill FR, Moodie EM, Freedman V, Fantes KH. 1982. Human interferon inhibits the growth of established human breast tumors in nude mice. Int J Cancer 30:231-235.
6. Beresford JN, Taylor GT, Triffitt JT. 1990. Interferons and bone. A comparison of the effects of interferon-α and interferon-γ in cultures of human bone-derived cells and an osteosarcoma cell line. Eur J Biochem 193:589-597.
7. Brosjö O, Bauer HCF, Broström L-Ä, Nilsson OS, Reinholt FP, Tribukait B. 1987. Growth inhibition of human osteosarcomas in nude mice by human interferon alpha: significance of dose and tumor differentiation. Cancer Res 47: 258-262.
8. Brosjö O, Bauer HCF, Broström L-Å, Nilsonne U, Nilsson OS, Reinholt FP, Strander H, Tribukait B. 1985. Influence of human alpha interferon on four human osteosarcoma xenografts in nude mice. Cancer Res 45:5598-5602.
9. Broxmeyer HE, Lu L, Platzer E, Feit C, Juliano L, Rubin BY. 1983. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multi-potential (CFU-GEMM), erythroid (BFU-e) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol 131:1300.
10. Colamonici OR, Pfeffer LM. 1991. Structure of the human interferon α receptor. Pharmac Ther 52:227-233.
11. 1 arrest in the inhibition of tumor cell growth by interferon. Proc Natl Acad Sci USA 77:1471-1475.
12. Dorr RT. 1993. Interferon-alpha in malignant and viral diseases. A review. Drugs 45:177-211.
13. Forster S, Triffitt JT, Bauer HCF, Brosjö O, Nilsson OS, Smith R, Sykes B. 1988. Interferon-inhibited human osteosarcoma xenografts induce host bone in nude mice. J Bone Miner Res 3:199-202.
14. Giles FJ, Singer CR, Gray AG, Yong KL, Brozovic M, Davies SC, Grant IR, Hoffbrand AV, Machin SJ, Mehta AB. 1988. Alpha-interferon therapy for essential thrombocythaemia. Lancet 2:70-72.
15. Gowen M, MacDonald BR, Russell RGG. 1988. Actions of recombinant human γ-interferon and tumor necrosis factor a on the proliferation and osteoblastic characteristics of human trabecular bone cells in vitro. Arthritis Rheum 31:1500-1507.
16. Gowen M, Nedwin GE, Mundy GR. 1986. Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gamma. J Bone Miner Res 1:469-474.
17. Gutterman JU. 1994. Cytokine therapeutics: lessons from interferon α. Proc Natl Acad Sci USA 91:1198-1205.
18. Haria M, Benfield P, 1995. Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis. Drugs 50:873-896.
19. Harju VT, Alitalo R, Andersson LC. 1990. Divergent in vitro effects of recombinant interferons on human osteosarcoma cells. Bone 11:247-251.
20. Hogan BLM. 1996. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10:1580-1594.
21. Inui K, Oreffo ROC, Triffitt JT. 1997. Effects of beta mercaptoethanol on the proliferation and differentiation of human osteoporogenitor cells. Cell Biol Int 21:429-435.
22. Jaramillo ML, Abraham N, Bell JC. 1995. The interferon system: a review with emphasis on the role of PKR in growth control. Cancer Invest 13:327-338.
23. Joyner CJ, Bennett A, Triffitt JT. 1997. Identification and enrichment of human osteoprogenitor cells by using differentiation stage-specific monoclonal antibodies. Bone 21:1-6.
24. Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V, Wang EA, Tanaka H, Suda T. 1990. The non-osteogenic mouse pluripotent cell line C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Comm 172:295-299.
25. Komaki M, Katagiri T, Suda T. 1996. Bone morphogenetic protein-2 does not alter the differentiation pathway of committed progenitors of osteoblasts and chondroblasts. Cell Tissue Res 284:9-17.
26. Lehman T, Beyeler C, Lammle B, Hunziker T, Vock P, Olah AJ, Dahinden C, Gerber NJ. 1996. Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2B. Br J Rheumatol 35:898-900.
27. Lengyel P. 1993. Tumor-suppressor genes: news about the interferon connection. Proc Natl Acad Sci USA 90:5893-5895.
28. Mamus SW, Oken MM, Zanjani ED. 1986. Suppression of normal human erythropoiesis by human recombinant DNA-produced alpha-2-interferon in vitro. Exp Hematol 14:1015-1022.
29. Mundy GR. 1996. Regulation of bone formation by bone morphogenetic proteins and other growth factors. Clin Orthop Rel Res 323:24-28.
30. Nii A, Reynolds DA, Young HA, Ward JM. 1997. Osteochondrodysplasia occurring in transgenic mice expressing interferon gamma. Vet Pathol 35:431-441.
31. Oreffo ROC, Bord S, Triffitt JT. 1998. Skeletal progenitor cells and ageing human populations. Clin Sci 94:549-555.
32. Oreffo ROC, Virdi AS, Triffitt JT. 1997. Modulation of osteogenesis by human serum in human bone marrow cultures. Eur J Cell Biol 74:251-261.
33. Owen ME, Cave J, Joyner CJ. 1987. Clonal analysis in vitro of osteogenic differentiation of marrow CFU-F. J Cell Sci 87:731-738.
34. Pestka S, Langer JA, Zoon KC, Samuel CE. 1987. Interferons and their actions. A Rev Biochem 56:727-777.
35. Skalla K. 1996. The interferons. Semin Oncol Nurs 12:97-105.
36. Silver RT. 1990. A new treatment for polycythemia vera: recombinant interferon alpha. Blood 76:664-665.
37. Smith DD, Gowen M, Mundy GR. 1987. Effects of interferon-gamma and other cytokines on collagen synthesis in fetal rat bone culture. Endocrinology 120:2494-2499.
38. Takahashi N, Mundy GR, Roodman GD. 1986. Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells. J Exp Med Immunol 137:3544-3549.
39. Thomas H, Balkwill FR. 1991. Effects of interferons and other cytokines on tumors in animals: a review. Pharmacol Ther 52:307-330.
40. Tiefenthaler M, Geisen F, Schirmer M, Konwalinka. 1997. Acomparison of the antiproliferative properties of recombinant human IFN-a2 and IFN-w in human bone marrow culture. J Interferon Cytokine Res 17:327-329.
41. Triffitt JT, Bauer HCF, Brosjö O, Joyner CJ, Forster S. 1989. Interferon effects on osteoinduction. Conn Tissue Res 23:145-151.
42. Triffitt JT. 1996. The stem cell of the osteoblast. In: Bilizekian J, Raisz L, Rodan G, editors. Principles of bone biology. San Diego, CA: Academic Press Inc. p 39-50.
43. Triffitt JT, Oreffo ROC. 1999. The osteoblast lineage. In: Zaidi M, editor. Molecular and cellular biology of bone. Advances in organ biology series. Stamford, CT: JAI Press Inc. vol 5B:429-451.
44. Uze G, Di Marco S, Mouchel Vielh E, Monneron D, Bandu MT, Horisberger MA, Dorques A, Lutfalla G, Mogensen KE. 1994. Domains of interaction between alpha interferon and its receptor components. J Mol Biol 243:245-257.
45. Virdi AS, Cook L, Oreffo ROC, Triffitt. 1998. Modulation of bone morphogenetic protein-2 and bone morphogenetic protein-4 gene expression in osteoblastic cell lines. Cell Mol Biol 44:1237-1246.
46. Vukicevic S, Luyten FP, Reddi AH. 1989. Stimulation of the expression of the osteogenic and chondrogenic pheno-types in vitro by osteogenin. Proc Natl Acad Sci USA 87:2220-2224.
47. Wang JC, Lang H-Dao, Liao P, Wong A. 1992. Recombinant alpha-interferon inhibits colony formation of bone marrow fibroblast progenitor cells (CFU-F). Am J Haematology 40:81-85.
48. West DC, Sattar A, Kumar S. 1985. A simplified in situ solubilization procedure for the determination of DNA and cell number in tissue cultured mammalian cells. Anal Biochem 147:289-295.
49. Yamaguchi A, Ishizuya T, Kintou N, Wada Y, Katagiri T, Wozney JM, Rosen V, Yoshiki S. 1996. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/ PA6. Biochem Biophys Res Commun 220:366-371.
50. Yoshihara R, Shiozawa S, Imai Y, Fujita T. 1990. Tumor necrosis factor alpha and interferon gamma inhibit proliferation and alkaline phosphatase activity of human osteoblastic Sa-OS-2 cell line. Lymphokine Res 9:59-66.